Akoya to Report First Quarter 2022 Financial Results on May 5, 2022

Akoya Biosciences, Inc.

MARLBOROUGH, Mass., April 14, 2022 (GLOBE NEWSWIRE) — Akoya Biosciences, Inc. (Nasdaq: AKYA) (“Akoya”), The Spatial Biology Company®, today announced that it will report financial results for the first quarter of 2022 after market close on Thursday, May 5e2022. Company management will host a conference call to discuss financial results at 5:00 p.m. ET.

Investors interested in listening to the conference call can do so by dialing (833) 562-0146 for domestic callers or (661) 567-1226 for international callers, followed by conference ID: 7363649. Live and archived footage of the event will be available in the “Investors” section of Akoya’s website at https://investors.akoyabio.com/.

About Akoya Biosciences
As a space biology society®, Akoya Biosciences’ mission is to put the world of biology and human health into context through the power of spatial phenotyping. The company offers comprehensive single-cell imaging solutions that allow researchers to phenotype cells with spatial context and visualize how they organize and interact to influence disease progression and response to treatment. Akoya offers a full continuum of spatial phenotyping solutions to meet the diverse needs of researchers in discovery, translational and clinical research through its key platforms: PhenoCycler™, PhenoImager™ Fusion and PhenoImager HT. To learn more about Akoya, visit www.akoyabio.com.

Investor contacts:
Priyam Shah
Senior Director, Investor Relations
Akoya Biosciences, Inc.
[email protected]

Media Contact:
michelle linn
Bioscribe, Inc.
774-696-3803
[email protected]

About Chris McCarter

Check Also

The global economy lends itself to divergence in the era of high interest rates

Climate affairs are now visible suffering in every nation, battles for each political leadership, while …